Our findings suggested that AQP9 expression had a moderate negative correlation with infiltrating levels of B cells in STAD and the markers of B cells such as CD19 and CD79A had no significant correlations with AQP9 expression, which may partly explain the favorable prognosis correlated with increased AQP9 expression in gastric cancer. This evidence concerns the gene CD19 and gastric adenocarcinoma.